See also this year's filing and all EDGAR filings for this company.
PDF Report 0001430306_2026_Tonix_Pharmaceuticals_Holding_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 228,876,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 120,000 |
| 2 | PropertyPlantAndEquipmentNet | 44,456,000 |
| 3 | remainder_Assets | 3,719,000 |
| 4 | LiabilitiesCurrent | 30,837,000 |
| 5 | LiabilitiesNoncurrent | 1,184,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 6,048,281 |
| 8 | SellingGeneralAndAdministrativeExpense | 325,014,269 |
| 9 | ResearchAndDevelopmentExpense | 45,565,549 |
| 10 | remainder_Expenses | 57,861,568 |
| 11 | remainder_Revenues | 14,949,539 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 4,259,118 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 277,171,000 |
| 1 | Liabilities | 32,021,000 |
| 2 | Expenses | 434,489,667 |
| 3 | Revenues | 14,949,539 |
| 4 | StockholdersEquity | 245,150,000 |
| 5 | NetIncome | -419,540,128 |
| 6 | ComprehensiveNetIncome | -417,410,569 |
| 7 | BaseVar | 381,445,162 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.757 |
| 9 | EconomicCapitalRatio | 2.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
